| MicroRNA in disease regulation | Lifetime | 2 | CN 1 | 99.96 |
| Cancer-related molecular mechanisms research | Lifetime | 4 | CN 1 | 99.97 |
| Circular RNAs in diseases | Lifetime | 4 | CN 1 | 99.93 |
| RNA modifications and cancer | Lifetime | 33 | CN 3 | 99.86 |
| Extracellular vesicles in disease | Lifetime | 13 | CN 3 | 99.76 |
| Genomics and Rare Diseases | Lifetime | 11 | CN 1 | 99.77 |
| Genomic variations and chromosomal abnormalities | Lifetime | 15 | CN 1 | 99.72 |
| Epigenetics and DNA Methylation | Lifetime | 107 | CN 6 | 99.61 |
| Ferroptosis and cancer prognosis | Lifetime | 32 | CN 10 | 99.36 |
| Advanced Sensor and Energy Harvesting Materials | Lifetime | 117 | CN 66 | 99.68 |
| Cancer Genomics and Diagnostics | Lifetime | 150 | CN 5 | 99.65 |
| Conducting polymers and applications | Lifetime | 182 | CN 59 | 99.64 |
| RNA Research and Splicing | Lifetime | 140 | CN 4 | 99.39 |
| Luminescence and Fluorescent Materials | Lifetime | 92 | CN 50 | 99.62 |
| Gene expression and cancer classification | Lifetime | 47 | CN 5 | 99.16 |
| Perovskite Materials and Applications | Lifetime | 152 | CN 77 | 99.53 |
| ZnO doping and properties | Lifetime | 164 | CN 49 | 99.37 |
| Supercapacitor Materials and Fabrication | Lifetime | 172 | CN 102 | 99.58 |
| RNA Interference and Gene Delivery | Lifetime | 258 | CN 42 | 99.18 |
| Bioinformatics and Genomic Networks | Lifetime | 100 | CN 8 | 98.89 |
| Quantum Dots Synthesis And Properties | Lifetime | 267 | CN 95 | 99.25 |
| Cancer-related gene regulation | Lifetime | 173 | CN 13 | 98.81 |
| Genomics and Phylogenetic Studies | Lifetime | 297 | CN 14 | 99.19 |
| Copper-based nanomaterials and applications | Lifetime | 184 | CN 91 | 99.11 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 171 | CN 1 | 98.91 |
| Molecular Sensors and Ion Detection | Lifetime | 186 | CN 77 | 98.97 |
| Advanced Photocatalysis Techniques | Lifetime | 458 | CN 296 | 99.29 |
| Transition Metal Oxide Nanomaterials | Lifetime | 172 | CN 49 | 98.51 |
| Nanoplatforms for cancer theranostics | Lifetime | 288 | CN 199 | 98.80 |
| Liver Disease Diagnosis and Treatment | Lifetime | 946 | CN 38 | 98.85 |
| MXene and MAX Phase Materials | Lifetime | 277 | CN 144 | 98.55 |
| Ga2O3 and related materials | Lifetime | 208 | CN 58 | 98.35 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 109 | CN 12 | 96.89 |
| Lung Cancer Treatments and Mutations | Lifetime | 548 | CN 23 | 98.79 |
| Molecular Biology Techniques and Applications | Lifetime | 251 | CN 10 | 97.85 |
| Advancements in Battery Materials | Lifetime | 647 | CN 385 | 99.05 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 322 | CN 21 | 98.59 |
| CRISPR and Genetic Engineering | Lifetime | 489 | CN 25 | 98.29 |
| Gas Sensing Nanomaterials and Sensors | Lifetime | 635 | CN 338 | 98.39 |
| Functional Brain Connectivity Studies | Lifetime | 464 | CN 20 | 98.80 |
| Genetic factors in colorectal cancer | Lifetime | 444 | CN 8 | 98.38 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 787 | CN 45 | 98.09 |
| RNA and protein synthesis mechanisms | Lifetime | 768 | CN 23 | 98.49 |
| Peptidase Inhibition and Analysis | Lifetime | 619 | CN 16 | 97.92 |
| Plasmonic and Surface Plasmon Research | Lifetime | 270 | CN 67 | 98.18 |
| Crystallography and molecular interactions | Lifetime | 248 | CN 22 | 98.13 |
| Genetic Associations and Epidemiology | Lifetime | 315 | CN 8 | 98.32 |
| Chalcogenide Semiconductor Thin Films | Lifetime | 673 | CN 192 | 97.92 |
| 2D Materials and Applications | Lifetime | 457 | CN 231 | 97.88 |
| Advanced Battery Materials and Technologies | Lifetime | 740 | CN 446 | 98.54 |
| Advanced Computational Techniques and Applications | Lifetime | 327 | CN 271 | 95.28 |
| Machine Learning in Bioinformatics | Lifetime | 166 | CN 36 | 97.20 |
| Nanowire Synthesis and Applications | Lifetime | 533 | CN 129 | 97.26 |
| Organic Light-Emitting Diodes Research | Lifetime | 392 | CN 176 | 97.81 |
| Photodynamic Therapy Research Studies | Lifetime | 280 | CN 49 | 96.90 |
| Thin-Film Transistor Technologies | Lifetime | 635 | CN 87 | 97.26 |
| Advanced Nanomaterials in Catalysis | Lifetime | 616 | CN 427 | 97.43 |
| Immune cells in cancer | Lifetime | 738 | CN 93 | 96.40 |
| Metal-Organic Frameworks: Synthesis and Applications | Lifetime | 870 | CN 374 | 97.51 |
| Solid-state spectroscopy and crystallography | Lifetime | 639 | CN 58 | 96.91 |
| Genetic Mapping and Diversity in Plants and Animals | Lifetime | 579 | CN 58 | 97.32 |
| Pluripotent Stem Cells Research | Lifetime | 583 | CN 44 | 96.72 |
| Porphyrin and Phthalocyanine Chemistry | Lifetime | 706 | CN 67 | 97.13 |
| Advanced Memory and Neural Computing | Lifetime | 956 | CN 299 | 96.38 |
| Angiogenesis and VEGF in Cancer | Lifetime | 680 | CN 26 | 96.19 |
| Autism Spectrum Disorder Research | Lifetime | 783 | CN 2 | 96.54 |
| Autophagy in Disease and Therapy | Lifetime | 659 | CN 107 | 96.10 |
| Cancer Mechanisms and Therapy | Lifetime | 420 | CN 63 | 95.84 |
| Retinal Diseases and Treatments | Lifetime | 950 | CN 39 | 97.42 |
| Inflammasome and immune disorders | Lifetime | 516 | CN 44 | 95.50 |
| Nonlinear Optical Materials Studies | Lifetime | 338 | CN 83 | 95.95 |
| CCD and CMOS Imaging Sensors | Lifetime | 576 | CN 64 | 94.62 |
| Catalytic C–H Functionalization Methods | Lifetime | 914 | CN 353 | 97.03 |
| Chromosomal and Genetic Variations | Lifetime | 876 | CN 51 | 95.84 |
| Congenital heart defects research | Lifetime | 682 | CN 21 | 95.34 |
| RNA regulation and disease | Lifetime | 712 | CN 25 | 94.85 |
| Sulfur-Based Synthesis Techniques | Lifetime | 641 | CN 215 | 95.94 |
| Neural and Behavioral Psychology Studies | Lifetime | 893 | CN 19 | 96.40 |
| Photoacoustic and Ultrasonic Imaging | Lifetime | 974 | CN 169 | 94.70 |
| Synthesis and Catalytic Reactions | Lifetime | 921 | CN 243 | 95.48 |
| Membrane-based Ion Separation Techniques | Lifetime | 650 | CN 212 | 95.15 |
| Innovative Energy Harvesting Technologies | Lifetime | 392 | CN 172 | 94.31 |
| Biomedical Text Mining and Ontologies | Lifetime | 559 | CN 39 | 94.06 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 863 | CN 106 | 93.77 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 754 | CN 9 | 94.87 |
| Signaling Pathways in Disease | Lifetime | 807 | CN 45 | 93.14 |
| Supramolecular Chemistry and Complexes | Lifetime | 643 | CN 154 | 94.45 |
| Advanced Measurement and Detection Methods | Lifetime | 855 | CN 511 | 89.64 |
| Fire Detection and Safety Systems | Lifetime | 223 | CN 94 | 91.78 |
| Power Systems and Technologies | Lifetime | 604 | CN 361 | 90.61 |
| Energetic Materials and Combustion | Lifetime | 963 | CN 282 | 93.26 |
| Sulfur Compounds in Biology | Lifetime | 702 | CN 205 | 92.74 |
| Smart Grid and Power Systems | Lifetime | 718 | CN 568 | 89.21 |
| VLSI and FPGA Design Techniques | Lifetime | 558 | CN 66 | 93.00 |
| Thermal Radiation and Cooling Technologies | Lifetime | 996 | CN 365 | 91.57 |
| Polydiacetylene-based materials and applications | Lifetime | 529 | CN 179 | 90.72 |
| Thermal Expansion and Ionic Conductivity | Lifetime | 779 | CN 216 | 90.21 |
| Advanced Graph Neural Networks | Lifetime | 654 | CN 363 | 90.99 |
| TGF-β signaling in diseases | Lifetime | 868 | CN 70 | 90.18 |
| Cancer-related cognitive impairment studies | Lifetime | 577 | CN 15 | 89.44 |
| Aerogels and thermal insulation | Lifetime | 825 | CN 316 | 88.45 |
| Electroconvulsive Therapy Studies | Lifetime | 795 | CN 10 | 89.76 |
| Emotion and Mood Recognition | Lifetime | 711 | CN 195 | 86.96 |
| Traditional Chinese Medicine and Integrative Care | Lifetime | 669 | CN 372 | 82.43 |
| Chromatin Remodeling and Cancer | Lifetime | 931 | CN 37 | 83.12 |
| Cognitive Functions and Memory | Lifetime | 685 | CN 14 | 80.00 |
| E-commerce and Technology Innovations | Lifetime | 380 | CN 270 | 69.88 |
| Grey System Theory Applications | Lifetime | 938 | CN 554 | 61.45 |
| Expert finding and Q&A systems | Lifetime | 781 | CN 216 | 60.98 |
| RNA modifications and cancer | 2021-2025 | 9 | CN 6 | 99.86 |
| MicroRNA in disease regulation | 2021-2025 | 10 | CN 6 | 99.74 |
| Cancer-related molecular mechanisms research | 2021-2025 | 17 | CN 11 | 99.78 |
| RNA Research and Splicing | 2021-2025 | 12 | CN 1 | 99.36 |
| Functional Brain Connectivity Studies | 2021-2025 | 31 | CN 5 | 99.51 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 21 | CN 11 | 98.78 |
| Copper-based nanomaterials and applications | 2021-2025 | 17 | CN 10 | 99.44 |
| Circular RNAs in diseases | 2021-2025 | 19 | CN 11 | 99.45 |
| Ferroptosis and cancer prognosis | 2021-2025 | 31 | CN 23 | 99.40 |
| Epigenetics and DNA Methylation | 2021-2025 | 44 | CN 21 | 98.62 |
| Advanced Photocatalysis Techniques | 2021-2025 | 114 | CN 83 | 99.64 |
| Luminescence and Fluorescent Materials | 2021-2025 | 60 | CN 52 | 99.20 |
| Advanced Sensor and Energy Harvesting Materials | 2021-2025 | 132 | CN 98 | 99.28 |
| Cancer-related gene regulation | 2021-2025 | 23 | CN 18 | 97.78 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 18 | CN 10 | 97.32 |
| Supercapacitor Materials and Fabrication | 2021-2025 | 157 | CN 108 | 98.94 |
| Conducting polymers and applications | 2021-2025 | 188 | CN 132 | 98.75 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 208 | CN 19 | 98.90 |
| Molecular Sensors and Ion Detection | 2021-2025 | 56 | CN 37 | 98.34 |
| Quantum Dots Synthesis And Properties | 2021-2025 | 115 | CN 77 | 98.42 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 67 | CN 12 | 97.86 |
| MXene and MAX Phase Materials | 2021-2025 | 139 | CN 90 | 98.30 |
| Immune cells in cancer | 2021-2025 | 111 | CN 65 | 97.28 |
| RNA Interference and Gene Delivery | 2021-2025 | 100 | CN 51 | 97.95 |
| Perovskite Materials and Applications | 2021-2025 | 263 | CN 188 | 98.58 |
| Transition Metal Oxide Nanomaterials | 2021-2025 | 57 | CN 27 | 96.99 |
| 2D Materials and Applications | 2021-2025 | 177 | CN 104 | 97.85 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 240 | CN 207 | 98.35 |
| Advancements in Battery Materials | 2021-2025 | 466 | CN 371 | 98.62 |
| Autophagy in Disease and Therapy | 2021-2025 | 87 | CN 39 | 96.08 |
| Metal-Organic Frameworks: Synthesis and Applications | 2021-2025 | 233 | CN 147 | 97.90 |
| Advanced Battery Materials and Technologies | 2021-2025 | 416 | CN 345 | 98.46 |
| ZnO doping and properties | 2021-2025 | 176 | CN 81 | 96.76 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 74 | CN 4 | 97.05 |
| Sulfur Compounds in Biology | 2021-2025 | 39 | CN 32 | 96.67 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 632 | CN 117 | 97.61 |
| Advanced Nanomaterials in Catalysis | 2021-2025 | 306 | CN 214 | 97.02 |
| Neural and Behavioral Psychology Studies | 2021-2025 | 112 | CN 7 | 95.76 |
| Peptidase Inhibition and Analysis | 2021-2025 | 190 | CN 42 | 95.68 |
| Extracellular vesicles in disease | 2021-2025 | 336 | CN 208 | 94.92 |
| RNA regulation and disease | 2021-2025 | 85 | CN 24 | 91.26 |
| Electronic and Structural Properties of Oxides | 2021-2025 | 247 | CN 130 | 94.29 |
| Gas Sensing Nanomaterials and Sensors | 2021-2025 | 606 | CN 396 | 95.41 |
| Cancer Genomics and Diagnostics | 2021-2025 | 874 | CN 66 | 94.94 |
| Membrane-based Ion Separation Techniques | 2021-2025 | 176 | CN 103 | 95.35 |
| Photonic and Optical Devices | 2021-2025 | 700 | CN 385 | 95.53 |
| Innovative Energy Harvesting Technologies | 2021-2025 | 99 | CN 73 | 95.01 |
| Advanced Memory and Neural Computing | 2021-2025 | 565 | CN 326 | 94.47 |
| Genomics and Rare Diseases | 2021-2025 | 305 | CN 10 | 92.91 |
| Neural dynamics and brain function | 2021-2025 | 411 | CN 106 | 94.64 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 777 | CN 166 | 95.22 |
| Organic Light-Emitting Diodes Research | 2021-2025 | 256 | CN 205 | 94.76 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 408 | CN 90 | 93.53 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 446 | CN 44 | 94.57 |
| Inflammasome and immune disorders | 2021-2025 | 266 | CN 134 | 91.48 |
| Bioinformatics and Genomic Networks | 2021-2025 | 235 | CN 94 | 90.56 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 964 | CN 42 | 92.92 |
| Aerogels and thermal insulation | 2021-2025 | 110 | CN 80 | 92.34 |
| RNA and protein synthesis mechanisms | 2021-2025 | 467 | CN 93 | 91.98 |
| Retinal Diseases and Treatments | 2021-2025 | 562 | CN 69 | 94.76 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 484 | CN 107 | 92.63 |
| Spacecraft and Cryogenic Technologies | 2021-2025 | 154 | CN 79 | 93.53 |
| Covalent Organic Framework Applications | 2021-2025 | 689 | CN 521 | 93.08 |
| Fuel Cells and Related Materials | 2021-2025 | 877 | CN 600 | 93.11 |
| Mental Health Research Topics | 2021-2025 | 507 | CN 70 | 92.32 |
| Catalytic C–H Functionalization Methods | 2021-2025 | 576 | CN 375 | 93.36 |
| Genetic Associations and Epidemiology | 2021-2025 | 534 | CN 61 | 90.74 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 605 | CN 176 | 89.74 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 338 | CN 206 | 88.29 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 793 | CN 200 | 92.61 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 879 | CN 278 | 89.52 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 523 | CN 37 | 88.51 |
| Glaucoma and retinal disorders | 2021-2025 | 812 | CN 123 | 92.04 |
| Tactile and Sensory Interactions | 2021-2025 | 359 | CN 221 | 90.12 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 90 | CN 20 | 86.91 |
| Layered Double Hydroxides Synthesis and Applications | 2021-2025 | 163 | CN 93 | 88.17 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 524 | CN 108 | 89.87 |
| Lignin and Wood Chemistry | 2021-2025 | 434 | CN 284 | 91.25 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 762 | CN 299 | 89.79 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 358 | CN 106 | 90.66 |
| Rock Mechanics and Modeling | 2021-2025 | 704 | CN 608 | 93.51 |
| Tryptophan and brain disorders | 2021-2025 | 771 | CN 231 | 88.67 |
| Ubiquitin and proteasome pathways | 2021-2025 | 516 | CN 225 | 86.96 |
| Polydiacetylene-based materials and applications | 2021-2025 | 149 | CN 101 | 88.23 |
| Fire Detection and Safety Systems | 2021-2025 | 108 | CN 62 | 87.84 |
| Attention Deficit Hyperactivity Disorder | 2021-2025 | 366 | CN 19 | 88.54 |
| Membrane Separation Technologies | 2021-2025 | 950 | CN 509 | 91.02 |
| Effects and risks of endocrine disrupting chemicals | 2021-2025 | 523 | CN 196 | 88.29 |
| TGF-β signaling in diseases | 2021-2025 | 38 | CN 14 | 85.37 |
| Retinal Imaging and Analysis | 2021-2025 | 803 | CN 136 | 89.60 |
| Adenosine and Purinergic Signaling | 2021-2025 | 180 | CN 35 | 85.37 |
| Corneal surgery and disorders | 2021-2025 | 632 | CN 134 | 89.77 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 345 | CN 140 | 84.87 |
| Autism Spectrum Disorder Research | 2021-2025 | 921 | CN 35 | 88.05 |
| Nuclear reactor physics and engineering | 2021-2025 | 745 | CN 258 | 86.05 |
| Porphyrin and Phthalocyanine Chemistry | 2021-2025 | 394 | CN 123 | 85.71 |
| Electroconvulsive Therapy Studies | 2021-2025 | 139 | CN 5 | 86.49 |
| Magnetic and transport properties of perovskites and related materials | 2021-2025 | 935 | CN 366 | 86.45 |
| Magnetic properties of thin films | 2021-2025 | 685 | CN 251 | 88.06 |
| Diet, Metabolism, and Disease | 2021-2025 | 684 | CN 132 | 84.89 |
| Cancer Mechanisms and Therapy | 2021-2025 | 391 | CN 155 | 83.40 |
| Ga2O3 and related materials | 2021-2025 | 718 | CN 397 | 87.04 |
| Advancements in Solid Oxide Fuel Cells | 2021-2025 | 525 | CN 307 | 88.04 |
| Signaling Pathways in Disease | 2021-2025 | 137 | CN 45 | 78.22 |
| Thermal Radiation and Cooling Technologies | 2021-2025 | 630 | CN 440 | 86.30 |
| Cancer Research and Treatments | 2021-2025 | 716 | CN 302 | 81.34 |
| Mechanical and Optical Resonators | 2021-2025 | 778 | CN 363 | 84.35 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 378 | CN 74 | 81.30 |
| Catalysts for Methane Reforming | 2021-2025 | 918 | CN 451 | 85.09 |
| Synthesis and Catalytic Reactions | 2021-2025 | 449 | CN 214 | 84.56 |
| Advanced Graph Neural Networks | 2021-2025 | 708 | CN 489 | 85.31 |
| Treatment of Major Depression | 2021-2025 | 472 | CN 40 | 84.66 |
| CCD and CMOS Imaging Sensors | 2021-2025 | 565 | CN 239 | 79.62 |
| Industrial Vision Systems and Defect Detection | 2021-2025 | 819 | CN 508 | 82.87 |
| Nuclear Engineering Thermal-Hydraulics | 2021-2025 | 273 | CN 132 | 84.51 |
| Ear and Head Tumors | 2021-2025 | 334 | CN 22 | 79.56 |
| Chemical Looping and Thermochemical Processes | 2021-2025 | 357 | CN 202 | 83.99 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 371 | CN 53 | 78.45 |
| Intraocular Surgery and Lenses | 2021-2025 | 791 | CN 125 | 81.37 |
| Solid-state spectroscopy and crystallography | 2021-2025 | 861 | CN 402 | 81.79 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 305 | CN 128 | 78.41 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 711 | CN 210 | 78.37 |
| Sulfur-Based Synthesis Techniques | 2021-2025 | 763 | CN 478 | 82.74 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 721 | CN 143 | 78.96 |
| Human Pose and Action Recognition | 2021-2025 | 955 | CN 557 | 82.09 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 667 | CN 164 | 76.47 |
| Phytochemistry and Biological Activities | 2021-2025 | 999 | CN 205 | 80.05 |
| Cancer Diagnosis and Treatment | 2021-2025 | 842 | CN 77 | 75.19 |
| Organic and Molecular Conductors Research | 2021-2025 | 248 | CN 97 | 77.70 |
| Trace Elements in Health | 2021-2025 | 698 | CN 267 | 77.22 |
| High Temperature Alloys and Creep | 2021-2025 | 684 | CN 473 | 80.79 |
| Congenital heart defects research | 2021-2025 | 707 | CN 106 | 75.27 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 785 | CN 186 | 75.91 |
| Cardiac tumors and thrombi | 2021-2025 | 596 | CN 58 | 74.71 |
| Psychosomatic Disorders and Their Treatments | 2021-2025 | 929 | CN 42 | 75.73 |
| Supramolecular Chemistry and Complexes | 2021-2025 | 623 | CN 332 | 77.10 |
| Enzyme-mediated dye degradation | 2021-2025 | 402 | CN 114 | 74.75 |
| Photodynamic Therapy Research Studies | 2021-2025 | 976 | CN 494 | 76.01 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 436 | CN 84 | 73.48 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 496 | CN 111 | 70.60 |
| Biomedical Text Mining and Ontologies | 2021-2025 | 648 | CN 131 | 70.77 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 910 | CN 44 | 72.73 |
| Lipid metabolism and disorders | 2021-2025 | 552 | CN 144 | 69.47 |
| Carcinogens and Genotoxicity Assessment | 2021-2025 | 636 | CN 94 | 68.26 |
| E-commerce and Technology Innovations | 2021-2025 | 125 | CN 93 | 70.50 |
| Optical Coatings and Gratings | 2021-2025 | 679 | CN 285 | 69.15 |
| Genetic Syndromes and Imprinting | 2021-2025 | 694 | CN 59 | 66.47 |
| Synthesis and Properties of Aromatic Compounds | 2021-2025 | 896 | CN 430 | 71.38 |
| Liver physiology and pathology | 2021-2025 | 891 | CN 386 | 67.27 |
| Machine Learning in Bioinformatics | 2021-2025 | 723 | CN 345 | 68.99 |
| Hand Gesture Recognition Systems | 2021-2025 | 864 | CN 325 | 66.72 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 570 | CN 46 | 64.56 |
| Vehicle License Plate Recognition | 2021-2025 | 423 | CN 138 | 65.00 |
| Advanced Bandit Algorithms Research | 2021-2025 | 423 | CN 191 | 65.85 |
| Galectins and Cancer Biology | 2021-2025 | 993 | CN 289 | 63.54 |
| Dam Engineering and Safety | 2021-2025 | 891 | CN 609 | 66.01 |
| stochastic dynamics and bifurcation | 2021-2025 | 649 | CN 362 | 67.14 |
| Spinal Dysraphism and Malformations | 2021-2025 | 844 | CN 94 | 60.84 |
| Advanced Thermodynamic Systems and Engines | 2021-2025 | 680 | CN 351 | 63.24 |
| Amino Acid Enzymes and Metabolism | 2021-2025 | 705 | CN 178 | 61.18 |
| Handwritten Text Recognition Techniques | 2021-2025 | 583 | CN 208 | 60.47 |
| Nausea and vomiting management | 2021-2025 | 888 | CN 197 | 59.36 |
| nanoparticles nucleation surface interactions | 2021-2025 | 945 | CN 277 | 59.51 |
| Superconductivity in MgB2 and Alloys | 2021-2025 | 650 | CN 260 | 58.26 |
| Tannin, Tannase and Anticancer Activities | 2021-2025 | 154 | CN 16 | 57.22 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 491 | CN 54 | 56.43 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 759 | CN 190 | 54.79 |
| Kruppel-like factors research | 2021-2025 | 651 | CN 251 | 55.24 |
| Surface Treatment and Residual Stress | 2021-2025 | 832 | CN 537 | 56.90 |
| Image Processing and 3D Reconstruction | 2021-2025 | 664 | CN 253 | 56.23 |
| Surface Roughness and Optical Measurements | 2021-2025 | 867 | CN 392 | 56.09 |
| Offshore Engineering and Technologies | 2021-2025 | 393 | CN 169 | 55.08 |
| Advanced Materials Characterization Techniques | 2021-2025 | 889 | CN 350 | 52.75 |
| Ion Channels and Receptors | 2021-2025 | 982 | CN 187 | 50.85 |
| Simulation Techniques and Applications | 2021-2025 | 429 | CN 54 | 43.60 |
| Hemispheric Asymmetry in Neuroscience | 2021-2025 | 229 | CN 10 | 39.51 |